Skip to main content
DAIICHI SANKYO COMPANY, LIMITED logo

DAIICHI SANKYO COMPANY, LIMITED — Investor Relations & Filings

Ticker · 4568 ISIN · JP3475350009 LEI · 353800XGIU2IHQGC9504 T Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2024-11-07 Interim / Quarterly Rep…
Country JP Japan
Listing T 4568

About DAIICHI SANKYO COMPANY, LIMITED

https://www.daiichisankyo.co.jp/

Daiichi Sankyo is an innovative global healthcare company focused on the research, development, and delivery of pharmaceutical solutions. By leveraging cutting-edge science, technology, and data analytics, the company develops novel medicines and medical treatments to address unmet needs. Its core mission is to contribute to the enrichment of quality of life for patients worldwide. The company maintains a robust R&D pipeline and actively engages in open innovation to advance its therapeutic offerings, with a significant focus on oncology and specialty medicines.

Recent filings

Filing Released Lang Actions
半期報告書－第20期(2024/04/01－2025/03/31)
Interim / Quarterly Report Classification · 1% confidence The document is a 'Semi-Annual Report' (半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis (MDA), and business performance data for the six-month period ending September 30, 2024. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2025
2024-11-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly states its legal basis as "金融商品取引法第24条の６第１項" (Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act). It details the acquisition and disposal status of treasury stock for the reporting period of October 1, 2024, to October 31, 2024. This type of filing specifically reports on the company's transactions involving its own shares (share repurchase/issuance). This directly corresponds to the definition for 'Transaction in Own Shares' (Code: POS). The document is a formal report detailing the activity, not merely an announcement of a report's publication.
2024-11-06 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is titled "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to "Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act)". It details the acquisition and disposal of treasury stock (own shares) for the reporting period of September 1, 2024, to September 30, 2024. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as Transaction in Own Shares (POS). The document is a detailed report, not just an announcement of a report, and its content is highly specific to share repurchases.
2024-10-11 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document is titled "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition) and explicitly states its basis as "金融商品取引法第24条の６第１項" (Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act). This type of filing in Japan details the monthly activity regarding the company's own share repurchases (treasury stock transactions) over a specific reporting period (August 1 to August 31, 2024). This specific reporting requirement for share repurchases does not directly map to the standard US SEC filings (10-K, ER, etc.) provided in the definitions. However, the content is a detailed report on capital structure changes related to share transactions, specifically share repurchases. The closest category that covers transactions in own shares is 'Transaction in Own Shares' (POS). While this is a regulatory report, POS is more specific than the general 'RNS' fallback for this type of detailed transaction report.
2024-09-05 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 1% confidence The document title is "自己株券買付状況報告書" (Report on the Status of Treasury Stock Acquisition). The filing explicitly states it is based on "金融商品取引法第24条の６第１項" (Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act). This type of report details the company's transactions involving its own shares (buybacks and disposals) over a specific monthly period (July 1 to July 31, 2024). This directly corresponds to the definition of a report on the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). Although it is a regulatory filing, POS is the most specific category available for treasury stock reports.
2024-08-08 Japanese
訂正有価証券届出書（参照方式）
Share Issue/Capital Change Classification · 1% confidence The document explicitly states in the header and throughout the text that it is a "訂正有価証券届出書（参照）" which translates to "Amended Securities Registration Statement (Reference)". A Securities Registration Statement (Yuka Shoken Todokedesho) in Japan is the primary filing used to register securities offerings with the financial authorities (Kanto Local Finance Bureau in this case). This document details the offering of new shares (59,133 shares of common stock) to directors and executive officers as part of a restricted stock compensation plan (譲渡制限付株式報酬制度). This type of filing, which registers a specific offering of securities, corresponds most closely to the regulatory filings category, but given the specific nature of registering an offering for capital/financing purposes, it aligns strongly with 'Capital/Financing Update' (CAP) or the general regulatory filing category. However, the core function is the registration of a securities offering, which is a mandatory disclosure under financial regulations, similar to a US registration statement. Since there isn't a direct 'Registration Statement' code, and this document details a capital change (issuance of shares for compensation), 'CAP' (Capital/Financing Update) is a strong candidate, but the document structure is fundamentally that of a formal regulatory registration filing. Given the options, 'CAP' covers the substance (issuance of shares for compensation/financing), but 'RNS' (Regulatory Filings) is the general catch-all for mandatory regulatory disclosures that don't fit elsewhere. Since this is a formal registration statement for a share issuance, and 'CAP' covers financing activities, I will lean towards 'CAP' as it describes the *purpose* of the filing, although 'RNS' is also plausible for a Japanese regulatory filing type not explicitly listed. Reviewing the definitions, 'CAP' is for 'Updates on company fundraising, financing activities, or capital structure changes.' Issuing shares via compensation is a capital structure change/financing activity. I will classify it as CAP, as it is more specific than the general RNS fallback.
2024-06-18 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.